MyFinsight
Home
Blog
About
Cash and cash
equivalents
$419,365K
(40.79%↑ Y/Y)
Short-term investments
$271,313K
Prepaid expenses and
other current assets
$29,583K
(167.74%↑ Y/Y)
Restricted cash
$317K
(-0.63%↓ Y/Y)
Total current assets
$720,578K
(133.02%↑ Y/Y)
Operating lease
right-of-use assets
$19,410K
(249.60%↑ Y/Y)
Other assets
$8,448K
(29.65%↑ Y/Y)
Goodwill
$1,968K
(-3.48%↓ Y/Y)
Property and equipment,
net
$1,781K
(158.12%↑ Y/Y)
Total assets
$752,185K
(132.13%↑ Y/Y)
Total liabilities and
stockholders' equity
$752,185K
(132.13%↑ Y/Y)
Total stockholders'
equity
$629,983K
(142.83%↑ Y/Y)
Total liabilities
$122,202K
(89.17%↑ Y/Y)
Accumulated deficit
-$2,699,283K
(-46.45%↓ Y/Y)
Accumulated other
comprehensive loss
-$2,665K
(3.16%↑ Y/Y)
Additional paid-in capital
$3,324,000K
(58.44%↑ Y/Y)
Total current
liabilities
$103,566K
(71.68%↑ Y/Y)
Operating lease
liabilities, net of current...
$16,834K
(591.33%↑ Y/Y)
Other non-current
liabilities
$1,802K
(-1.96%↓ Y/Y)
Common stock, 0.01 par
value 1,000,000,000...
$7,931K
(6.77%↑ Y/Y)
Accrued liabilities
$65,055K
(148.80%↑ Y/Y)
Accounts payable
$22,896K
(-0.37%↓ Y/Y)
Accrued compensation
$9,443K
(43.25%↑ Y/Y)
Operating lease
liabilities, current portion
$3,550K
(13.86%↑ Y/Y)
Other current
liabilities
$2,622K
(76.57%↑ Y/Y)
Back
Back
Balance Sheet
summitplc-logo_05fd32df-svg
Summit Therapeutics Inc. (SMMT)
summitplc-logo_05fd32df-svg
Summit Therapeutics Inc. (SMMT)
source: myfinsight.com